Français
ItalianoBond Advanz Pharma Corp 8% ( US20653PAB85 ) in USD
| Issuer | Advanz Pharma Corp | ||||||||||
| Market price | 100 % ▼ | ||||||||||
| Country |  Canada
|
||||||||||
| ISIN code |
 US20653PAB85 ( in USD )
|
||||||||||
| Interest rate | 8% per year ( payment 2 times a year) | ||||||||||
| Maturity | 09/05/2024 - Bond has expired | ||||||||||
| Minimal amount | 1 000 USD | ||||||||||
| Total amount | 299 972 000 USD | ||||||||||
| Cusip | 20653PAB8 | ||||||||||
| Standard & Poor's ( S&P ) rating | N/A | ||||||||||
| Moody's rating | N/A | ||||||||||
| Detailed description |
Advanz Pharma Corp is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded and generic prescription drugs, primarily in the areas of central nervous system, pain management, and gastroenterology. Advanz Pharma Corp's USD 8% bond (ISIN: US20653PAB85, CUSIP: 20653PAB8), issued in Canada with a total issuance size of $299,972,000 and a minimum purchase size of $1,000, matured on 05/09/2024 and has been redeemed at 100% of face value, paying semi-annually. |
||||||||||
| |||||||||||